Assignee
DELMAR PHARMACEUTICALS INC
CA·8 granted patents·4 pending applications·11 citations·filing 2013–2018
Top patents by PatentIndex Score
12 records- 0185US9901563B2Compositions to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitolDELMAR PHARMACEUTICALS INC·Filed 2015·Granted Feb 27, 2018·2 cites·10 claims
- 0281US9687466B2Use of dianhydrogalactitol and analogs and derivatives thereof to treat glioblastoma multiformeDELMAR PHARMACEUTICALS INC·Filed 2014·Granted Jun 27, 2017·5 cites·42 claims
- 0372US9814693B2Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignanciesDELMAR PHARMACEUTICALS INC·Filed 2013·Granted Nov 14, 2017·2 cites·5 claims
- 0471US11446274B2Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pediatric central nervous system malignanciesDELMAR PHARMACEUTICALS INC·Filed 2016·Granted Sep 20, 2022·1 cites·4 claims
- 0562US11026914B2Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant glioma or progressive secondary brain tumorDELMAR PHARMACEUTICALS INC·Filed 2015·Granted Jun 8, 2021·1 cites·8 claims
- 0658US2017266150A1Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multforme and medulloblastomaDELMAR PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0758US2018147178A1Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitolDELMAR PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0857US10145824B2Analytical methods for analyzing and determining impurities in dianhydrogalactitolDELMAR PHARMACEUTICALS INC·Filed 2013·Granted Dec 4, 2018·0 cites·42 claims
- 0955US11541027B2Use of dianhydrogalactitol and analogs or derivatives thereof in combination with platinum-containing antineoplastic agents to treat non-small-cell carcinoma of the lung and brain metastasesDELMAR PHARMACEUTICALS INC·Filed 2015·Granted Jan 3, 2023·0 cites·33 claims
- 1053US2019183843A9Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pediatric central nervous system malignanciesDELMAR PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1152US9630938B2Method of synthesis of substituted hexitols such as dianhydrogalactitolDELMAR PHARMACEUTICALS INC·Filed 2014·Granted Apr 25, 2017·0 cites·27 claims
- 1229US2019015379A1Use of dianhydrogalactitol and analogs and derivatives thereof, together with radiation, to treat non-small-cell carcinoma of the lung and glioblastoma multiforme and suppress proliferation of cancer stem cellsDELMAR PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →